Wang H - Search Results

1

[Efficacy and Safety of Bevacizumab Combined with Chemotherapy as Second-line or Later-line Treatment in Advanced Nonsquamous Non-small Cell Lung Cancer].

Zheng X, Wang H, Zhang G, Yan X, Ma Z. Zheng X, et al. Among authors: wang h. Zhongguo Fei Ai Za Zhi. 2018 Jul 20;21(7):513-518. doi: 10.3779/j.issn.1009-3419.2018.07.02. Zhongguo Fei Ai Za Zhi. 2018. PMID: 30037370 Free PMC article. Chinese.

2

Erlotinib-based perioperative adjuvant therapy for a case of unresectable stage IIIA (N2) nonsmall cell lung cancer.

Wang Q, Wang H, Li P, Zhu H, He C, Wei B, Ma J, Ma Z. Wang Q, et al. Among authors: wang h. Am J Med Sci. 2010 Oct;340(4):321-5. doi: 10.1097/MAJ.0b013e3181e59ac2. Am J Med Sci. 2010. PMID: 20601859

3

[Research progresses of albumin-bound paclitaxel in the treatment of non-small cell lung cancer].

Li P, Wang Q, Wang H, Ma Z. Li P, et al. Among authors: wang h, wang q. Zhongguo Fei Ai Za Zhi. 2010 Jul;13(7):748-52. doi: 10.3779/j.issn.1009-3419.2010.07.16. Zhongguo Fei Ai Za Zhi. 2010. PMID: 20673493 Free PMC article. Review. Chinese. No abstract available.

4

[The role of adjuvant chemotherapy in operable non-small cell lung cancer].

Yan X, Zhu H, Wang H, Wang Q, Li P, Ma Z. Yan X, et al. Among authors: wang h, wang q. Zhongguo Fei Ai Za Zhi. 2011 Mar;14(3):281-5. doi: 10.3779/j.issn.1009-3419.2011.03.15. Zhongguo Fei Ai Za Zhi. 2011. PMID: 21426675 Free PMC article. Review. Chinese.

5

[A new target in non-small cell lung cancer: EML4-ALK fusion gene].

Wang H, Yuan J, Ma Z. Wang H, et al. Zhongguo Fei Ai Za Zhi. 2011 Jun;14(6):538-42. doi: 10.3779/j.issn.1009-3419.2011.06.11. Zhongguo Fei Ai Za Zhi. 2011. PMID: 21645460 Free PMC article. Review. Chinese.

6

MicroRNAs: novel biomarkers for lung cancer diagnosis, prediction and treatment.

Wang Q, Wang S, Wang H, Li P, Ma Z. Wang Q, et al. Among authors: wang h, wang s. Exp Biol Med (Maywood). 2012 Mar;237(3):227-35. doi: 10.1258/ebm.2011.011192. Epub 2012 Feb 16. Exp Biol Med (Maywood). 2012. PMID: 22345301 Review.

7

Differential efficacy of gefitinib across age groups in treatment of advanced lung adenocarcinoma.

Wang H, Zhang G, Li P, Yan X, Wang Q, Zhu H, Qi G, Fan Q, Ma Z. Wang H, et al. Among authors: wang q. Pharmazie. 2012 Jan;67(1):80-5. Pharmazie. 2012. PMID: 22393836

8

[Thyroid transcription factor-1 level is associated with epidermal growth factor receptor mutation status in patients with advanced lung adenocarcinoma].

Niu Y, Wang H, Zhang G, Ma J, Wei B, Ma Z. Niu Y, et al. Among authors: wang h. Zhonghua Jie He He Hu Xi Za Zhi. 2014 Dec;37(12):919-23. Zhonghua Jie He He Hu Xi Za Zhi. 2014. PMID: 25609130 Chinese.

9

[Current Status and Development of Traditional Chemotherapy in Non-small Cell Lung Cancer under the Background of Targeted Therapy].

Zhang G, Wang H, Zhang M, Li P, Ma Z. Zhang G, et al. Among authors: wang h. Zhongguo Fei Ai Za Zhi. 2015 Sep 20;18(9):587-91. doi: 10.3779/j.issn.1009-3419.2015.09.10. Zhongguo Fei Ai Za Zhi. 2015. PMID: 26383984 Free PMC article. Review. Chinese.

10

[Diagnosis and Treatment of Multiple Primary Lung Cancer].

Hou J, Wang H, Zhang G, Ma Z. Hou J, et al. Among authors: wang h. Zhongguo Fei Ai Za Zhi. 2015 Dec;18(12):764-9. doi: 10.3779/j.issn.1009-3419.2015.12.09. Zhongguo Fei Ai Za Zhi. 2015. PMID: 26706954 Free PMC article. Review. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

151,313 results

Search Page

Filters